Literature DB >> 8889325

Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela.

J Convit1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8889325     DOI: 10.1016/0738-081x(96)00042-9

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  4 in total

1.  Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.

Authors:  Shraddha Kumari; Mukesh Samant; Prashant Khare; Pragya Misra; Sujoy Dutta; Bala Krishna Kolli; Sharad Sharma; Kwang Poo Chang; Anuradha Dube
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

Review 2.  [Cutaneous leishmaniasis as travelers' disease. Clinical presentation, diagnostics and therapy].

Authors:  E von Stebut; U Schleicher; C Bogdan
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

3.  Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants.

Authors:  T Aebischer; M Wolfram; S I Patzer; T Ilg; M Wiese; P Overath
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Concurrent Chagas' disease and borderline disseminated cutaneous leishmaniasis: The role of amiodarone as an antitrypanosomatidae drug.

Authors:  Alberto E Paniz-Mondolfi; Alexandra M Pérez-Alvarez; Oscar Reyes-Jaimes; Gustavo Socorro; Olga Zerpa; Denisa Slova; Juan L Concepción
Journal:  Ther Clin Risk Manag       Date:  2008-06       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.